|
[Related PubMed/MEDLINE]
Total Number of Papers: 729
|
|
|
|
|
[Display Entries]
|
|
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
|
Page: of
|
|
|
|
| Abbreviation |
: mpMRI |
| Long Form |
: multiparametric magnetic resonance imaging |
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2020 |
A 3D/2D Hybrid U-Net CNN approach to prostate organ segmentation of mpMRI. |
CNN |
| 2 |
2020 |
A deep learning methodology for improved breast cancer diagnosis using multiparametric MRI. |
AUCs, CNN, DCE, ROC, T2W |
| 3 |
2020 |
A Multicenter Study of the Clinical Utility of Nontargeted Systematic Transperineal Prostate Biopsies in Patients Undergoing Pre-Biopsy Multiparametric Magnetic Resonance Imaging. |
csPCa |
| 4 |
2020 |
A non-randomized prospective study on the diagnostic performance of perineal prostatic biopsy, directed via diffusion nuclear resonance, in patients with suspected prostate cancer and previous negative transrectal prostate biopsy. |
PCa, PSA, TPUS-GB, TRUS-GB |
| 5 |
2020 |
A novel nomogram to identify candidates for active surveillance amongst patients with International Society of Urological Pathology (ISUP) Grade Group (GG) 1 or ISUP GG2 prostate cancer, according to multiparametric magnetic resonance imaging findings. |
AS, AUC, csPCa, EAU, ECE, GG, ISUP, JH, PCa, PI-RADS, pN, PRIAS, PSAD, pT, RP |
| 6 |
2020 |
A prospective, multi-centre trial of multi-parametric MRI as a biomarker in anal carcinoma. |
ADC, CRT, DCE-MRI, DW-MRI, SCCAC, SD |
| 7 |
2020 |
Accuracy of Sampling PI-RADS 4-5 Index Lesions Alone by MRI-guided In-bore Biopsy in Biopsy-naive Patients Undergoing Radical Prostatectomy. |
GG, PCa, PI-RADS, RP |
| 8 |
2020 |
Active Surveillance of Grade Group 1 Prostate Cancer: Long-term Outcomes from a Large Prospective Cohort. |
AS, GG, PCa, PSA |
| 9 |
2020 |
Additional Value of Dynamic Contrast-enhanced Sequences in Multiparametric Prostate Magnetic Resonance Imaging: Data from the PROMIS Study. |
DCE, TPM |
| 10 |
2020 |
Additive Value of Transrectal Systematic Ventral Biopsies in Combination with Magnet Resonance Imaging/Ultrasound Fusion-Guided Biopsy in Patients with 3 or More Negative Prostate Biopsies. |
PCa, SB, TB |
| 11 |
2020 |
Advanced zoomed diffusion-weighted imaging vs. full-field-of-view diffusion-weighted imaging in prostate cancer detection: a radiomic features study. |
ADC, AUC, f-DWIb1500, PCa, z-DWIb1500 |
| 12 |
2020 |
Applications of Artificial Intelligence to Prostate Multiparametric MRI (mpMRI): Current and Emerging Trends. |
ML |
| 13 |
2020 |
Association between PSA density and prostate cancer in men without significant MRI lesions. |
--- |
| 14 |
2020 |
Automatic intraprostatic lesion segmentation in multiparametric magnetic resonance images with proposed multiple branch UNet. |
ADC, DSC, DWI, MB-UNet, PI-RADS, T2W |
| 15 |
2020 |
Avoiding Unnecessary Magnetic Resonance Imaging (MRI) and Biopsies: Negative and Positive Predictive Value of MRI According to Prostate-specific Antigen Density, 4Kscore and Risk Calculators. |
csPCs, ERSPC-RC, MRI, PC, PSAD |
| 16 |
2020 |
Can clinical radiomics nomogram based on 3D multiparametric MRI features and clinical characteristics estimate early recurrence of pelvic chondrosarcoma? |
ACC, AUC, CET1 -w, CS, DWI, ER, OR, T1 -w, T2 -w |
| 17 |
2020 |
Can multiparametric magnetic resonance of the prostate avoid biopsies in patients with elevated PSA and surgical indication for benign prostatic enlargement? |
BPE, CsPCa |
| 18 |
2020 |
Can multiparametric ultrasound improve cognitive MRI/TRUS fusion prostate biopsy. |
CEUS, PCa, TRES |
| 19 |
2020 |
Can the Use of Serial Multiparametric Magnetic Resonance Imaging During Active Surveillance of Prostate Cancer Avoid the Need for Prostate Biopsies?-A Systematic Diagnostic Test Accuracy Review. |
AS, CI, PRISMA |
| 20 |
2020 |
Characteristics of Cancer Progression on Serial Biopsy in Men on Active Surveillance for Early-stage Prostate Cancer: Implications for Focal Therapy. |
AS, DT, FT, GG |
| 21 |
2020 |
Clinical evaluation and disease management of PI-RADS 3 lesions. Analysis from a single tertiary high-volume center. |
AS, CS, MVA, PCa, PI-RADS, PRIAS |
| 22 |
2020 |
Clinical Utility of 4Kscore, ExosomeDx and Magnetic Resonance Imaging for the Early Detection of High-Grade Prostate Cancer. |
GG, PCa |
| 23 |
2020 |
Clinical utility of combined T2-weighted imaging and T2-mapping in the detection of prostate cancer: a multi-observer study. |
FSE, ICC, NPVs, PPVs, PZ, Sn, Sp, TZ |
| 24 |
2020 |
Combination of Multiparametric Magnetic Resonance Imaging With Elastic-fusion Biopsy Has a High Sensitivity in Detecting Clinically Significant Prostate Cancer in Daily Practice. |
CS, IL, MRI-IL, PCa, PI-RADSv2 |
| 25 |
2020 |
Combining prostate health index and multiparametric magnetic resonance imaging in the diagnosis of clinically significant prostate cancer in an Asian population. |
CSPC, NPV, PHI, PI-RADSv2, PPV |
| 26 |
2020 |
Comparison of 68Ga-prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) and multi-parametric magnetic resonance imaging (MRI) in the evaluation of tumor extension of primary prostate cancer. |
ECE, MRI, NPV, PET/CT, PPV, PSMA, SVI |
| 27 |
2020 |
Comparison of 68Ga-PSMA-I/T PET-CT and Multiparametric MRI for Locoregional Staging of Prostate Cancer Patients: A Pilot Study. |
BNI, ECE, LNM, PCa, RP, SVI |
| 28 |
2020 |
Comparison of clinically significant prostate cancer detection by MRI cognitive biopsy and in-bore MRI-targeted biopsy for naive biopsy patients. |
COG, IB, PCa |
| 29 |
2020 |
Comparison of Histogram-based Textural Features between Cancerous and Normal Prostatic Tissue in Multiparametric Magnetic Resonance Images. |
ADC, AUC, DW, MANOVA, PZ, T2W |
| 30 |
2020 |
Comparison of micro-ultrasound and multiparametric magnetic resonance imaging for prostate cancer: A multicenter, prospective analysis. |
NPV, PPV |
| 31 |
2020 |
Comparison of multiple abbreviated multiparametric MRI-derived protocols for the detection of clinically significant prostate cancer. |
CDR, cesMRI, csPCa, DCE, FDR, PI-RADSv2, RP, sMRI |
| 32 |
2020 |
Concordance Between Biopsy and Radical Prostatectomy Pathology in the Era of Targeted Biopsy: A Systematic Review and Meta-analysis. |
CI, OR, PRISMA, QUADAS-2 |
| 33 |
2020 |
Confirmatory multiparametric magnetic resonance imaging at recruitment confers prolonged stay in active surveillance and decreases the rate of upgrading at follow-up. |
AS, B-PFS, PFS, RP |
| 34 |
2020 |
Conspicuity of prostate cancer on multiparametric magnetic resonance imaging: A cross-disciplinary translational hypothesis. |
--- |
| 35 |
2020 |
Correlation of Prostate-Imaging Reporting and Data Scoring System scoring on multiparametric prostate magnetic resonance imaging with histopathological factors in radical prostatectomy material in Turkish prostate cancer patients: a multicenter study of the Urooncology Association. |
PCa, PI-RADS, RP |
| 36 |
2020 |
Could Bladder Multiparametric MRI Be Introduced in Routine Clinical Practice? Role of the New VI-RADS Score: Results From a Prospective Study. |
CI, MIBC, NMIBC, TURB, VI-RADS |
| 37 |
2020 |
Current status and future prospective of focal therapy for localized prostate cancer: development of multiparametric MRI, MRI-TRUS fusion image-guided biopsy, and treatment modalities. |
CSPC, TRUS |
| 38 |
2020 |
Deep learning-based fully automated detection and segmentation of lymph nodes on multiparametric-mri for rectal cancer: A multicentre study. |
auto-LNDS, DSC, DWI, LNs, PPV, RC, T2WI |
| 39 |
2020 |
Detectability of prostate cancer in different parts of the gland with 3-Tesla multiparametric magnetic resonance imaging: correlation with whole-mount histopathology. |
PI-RADSv2, PZ, TZ |
| 40 |
2020 |
Detection of clinically significant prostate cancer in biopsy-naive men: direct comparison of systematic biopsy, multiparametric MRI- and contrast-ultrasound-dispersion imaging-targeted biopsy. |
csPCa, CUDI, GG |
| 41 |
2020 |
Detection of Significant Prostate Cancer Using Target Saturation in Transperineal Magnetic Resonance Imaging/Transrectal Ultrasonography-fusion Biopsy. |
MRI, PC, SBs, sPC, TBs, TRUS, TS |
| 42 |
2020 |
Development and External Validation of a Novel Nomogram to Predict Side-specific Extraprostatic Extension in Patients with Prostate Cancer Undergoing Radical Prostatectomy. |
AUC, CI, EPE, ISUP, PSA, RP |
| 43 |
2020 |
Diagnostic accuracy of biparametric versus multiparametric prostate MRI: assessment of contrast benefit in clinical practice. |
bpMRI, csPCa, DCE |
| 44 |
2020 |
Diagnostic Accuracy of Multiparametric MRI for Local Staging of Bladder Cancer: A Systematic Review and Meta-Analysis. |
UBC |
| 45 |
2020 |
Diagnostic value of retrospectively fused 64CuCl2 PET/MRI in biochemical relapse of prostate cancer: comparison with fused 18F-Choline PET/MRI, 64CuCl2 PET/CT, 18F-Choline PET/CT, and mpMRI. |
DRs, PCa, RP, RT |
| 46 |
2020 |
Do patients who undergo multiparametric MRI for prostate cancer benefit from additional staging imaging? Results from a statewide collaborative. |
BS, BVC, CT, LN |
| 47 |
2020 |
Does the administration of preoperative pembrolizumab lead to sustained remission post-cystectomy? First survival outcomes from the PURE-01 study☆. |
CI, CR, EFS, IQR, NAC, OS, RC, RFS |
| 48 |
2020 |
DWI and PRECISE criteria in men on active surveillance for prostate cancer: A multicentre preliminary experience of different ADC calculations. |
ADC, AS, ICC, PCa |
| 49 |
2020 |
Early oncological control following partial gland cryo-ablation: a prospective experience specifying reflex MRI guided biopsy of the ablation zone. |
AUC, OR, PSA |
| 50 |
2020 |
Effect of pelvimetric diameters on success of surgery in patients submitted to robot-assisted perineal radical prostatectomy. |
R-PRP |
| 51 |
2020 |
Effects of "real life" prostate MRI inter-observer variability on total needle samples and indication for biopsy. |
MRGpB, PI-RADS |
| 52 |
2020 |
Effects of the addition of quantitative apparent diffusion coefficient data on the diagnostic performance of the PI-RADS v2 scoring system to detect clinically significant prostate cancer. |
ADC, csPCa, PI-RADSv2 |
| 53 |
2020 |
Evolution of Targeted Prostate Biopsy by Adding Micro-Ultrasound to the Magnetic Resonance Imaging Pathway. |
csPCa, ISUP, micro-US, MRI, PCa, PRI-MUS |
| 54 |
2020 |
Exploring Patient Views and Acceptance of Multiparametric Magnetic Resonance Imaging for the Investigation of Suspected Prostate Cancer (the PACT Study): A Mixed-Methods Study Protocol. |
--- |
| 55 |
2020 |
External validation of novel magnetic resonance imaging-based models for prostate cancer prediction. |
AUC, ERSPC, PCa, PI-RADS, ROC |
| 56 |
2020 |
External validation of the Briganti nomogram predicting lymph node invasion in patients with intermediate and high-risk prostate cancer diagnosed with magnetic resonance imaging-targeted and systematic biopsies: A European multicenter study. |
LNI |
| 57 |
2020 |
Factors Influencing Variability in the Performance of Multiparametric Magnetic Resonance Imaging in Detecting Clinically Significant Prostate Cancer: A Systematic Literature Review. |
CAD, csPCa, PI-RADS |
| 58 |
2020 |
False Positive Multiparametric Magnetic Resonance Imaging Phenotypes in the Biopsy-naive Prostate: Are They Distinct from Significant Cancer-associated Lesions? Lessons from PROMIS. |
ADC, MRI, PROMIS, PSA, TPM |
| 59 |
2020 |
Financial implications of biparametric prostate MRI. |
bpMRI, DCE |
| 60 |
2020 |
Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort Study. |
AS, CI, EFS, MRI, PY, TFS, UCLH |
| 61 |
2020 |
Focal therapy for localized prostate cancer in the era of routine multi-parametric MRI. |
HIFU |
| 62 |
2020 |
Fully Automatic Calibration of Tumor-Growth Models Using a Single mpMRI Scan. |
GBM, PDE, TIL |
| 63 |
2020 |
Genetic Landscape of Prostate Cancer Conspicuity on Multiparametric Magnetic Resonance Imaging: A Systematic Review and Bioinformatic Analysis. |
MRI, PRISMA, PTEN |
| 64 |
2020 |
Histological comparison between predictive value of preoperative 3-T multiparametric MRI and 68 Ga-PSMA PET/CT scan for pathological outcomes at radical prostatectomy and pelvic lymph node dissection for prostate cancer. |
CAPRA, ISUP, LNM, MSKCC, PI-RADS, PLND, RALP |
| 65 |
2020 |
Histological findings of totally embedded robot assisted laparoscopic radical prostatectomy (RALP) specimens in 1197 men with a negative (low risk) preoperative multiparametric magnetic resonance imaging (mpMRI) prostate lobe and clinical implications. |
ISUP, PI-RADS, RALP |
| 66 |
2020 |
Histomorphological analysis of false positive PI-RADS 4 and 5 lesions. |
ROI, SB, TB |
| 67 |
2020 |
Histopathology-validated machine learning radiographic biomarker for noninvasive discrimination between true progression and pseudo-progression in glioblastoma. |
AUC, PsP, TP |
| 68 |
2020 |
How Many Cores Should be Obtained During Saturation Biopsy in the Era of Multiparametric Magnetic Resonance? Experience in 875 Patients Submitted to Repeat Prostate Biopsy. |
csPCa, GG |
| 69 |
2020 |
How Often Does Magnetic Resonance Imaging Detect Prostate Cancer Missed by Transrectal Ultrasound? |
AS, GG, IQR, PCa, PI-RADS, TRUS |
| 70 |
2020 |
How to make clinical decisions to avoid unnecessary prostate screening in biopsy-naive men with PI-RADs v2 score ≤ 3? |
AUC, CIPCa, csPCa, NPV, PCa, PI-RADSv2, PSA, PSAD, PV, ROC |
| 71 |
2020 |
Imaging protocols for renal multiparametric MRI and MR urography: results of a consensus conference from the French Society of Genitourinary Imaging. |
MRU |
| 72 |
2020 |
Imaging quality and prostate MR: it's time to improve. |
PI-QUAL |
| 73 |
2020 |
Imaging-based prostate cancer screening among BRCA mutation carriers-results from the first round of screening. |
PCa, PSA |
| 74 |
2020 |
Impact of preoperative prostate magnetic resonance imaging on the surgical management of high-risk prostate cancer. |
HRPC |
| 75 |
2020 |
Impact of surgically maximized versus native membranous urethral length on 30-day and long-term pad-free continence after robot-assisted radical prostatectomy. |
MUL, RARP |
| 76 |
2020 |
Impact of the MyProstateScore (MPS) Test on the Clinical Decision to Undergo Prostate Biopsy: Results From a Contemporary Academic Practice. |
CI, MPS, OR, PCPTrc |
| 77 |
2020 |
Improved detection and reduced biopsies: the effect of a multiparametric magnetic resonance imaging-based triage prostate cancer pathway in a public teaching hospital. |
csPCa, stTPB |
| 78 |
2020 |
Improvement of the intermediate risk prostate cancer sub-classification by integrating MRI and fusion biopsy features. |
AUC, GG, IRC, OUD, TB |
| 79 |
2020 |
Incidentalomas of the prostate detected by 18-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography. |
FDG PET, PCa, PSA |
| 80 |
2020 |
Incremental Value of Ga-68 Prostate-Specific Membrane Antigen-11 Positron-Emission Tomography/Computed Tomography Scan for Preoperative Risk Stratification of Prostate Cancer. |
PC, PET/CT |
| 81 |
2020 |
Independent external validation of nomogram to predict extracapsular extension in patients with prostate cancer. |
ECE, GCN, PCa, RP |
| 82 |
2020 |
Initial experience with SelectMDx in the diagnosis of prostate cancer in a real-world evidence clinical practice setting. |
CS-PC, PB, PC |
| 83 |
2020 |
Integrated Biophysical Modeling and Image Analysis: Application to Neuro-Oncology. |
CNS, WHO |
| 84 |
2020 |
Integrated Multiparametric Radiomics and Informatics System for Characterizing Breast Tumor Characteristics with the OncotypeDX Gene Assay. |
ADC, AUC, EHR, IRIS, mpRad |
| 85 |
2020 |
Intraindividual comparison between 68Ga-PSMA-PET/CT and mpMRI for intraprostatic tumor delineation in patients with primary prostate cancer: a retrospective analysis in 101 patients. |
GTV, PCa, PSMA-PET |
| 86 |
2020 |
Is dynamic contrast enhancement still necessary in multiparametric magnetic resonance for diagnosis of prostate cancer: a systematic review and meta-analysis. |
bpMRI, DCE, PCa |
| 87 |
2020 |
Is There Still a Need for Repeated Systematic Biopsies in Patients with Previous Negative Biopsies in the Era of Magnetic Resonance Imaging-targeted Biopsies of the Prostate? |
CI, cisPCa, COG-TB, csPCa, FUS-TB, MRI, PCa, PI-RADS, SBs, TBs |
| 88 |
2020 |
Lesion location agreement between prostatic multiparametric magnetic resonance, cognitive fusion biopsy and radical prostatectomy piece. |
PB, PCa, RP, SS |
| 89 |
2020 |
Likert vs PI-RADS v2: a comparison of two radiological scoring systems for detection of clinically significant prostate cancer. |
CCL, IQR, PI-RADS, ROC |
| 90 |
2020 |
Mischievous malakoplakia: A potential pitfall of mpMRI of the prostate? |
--- |
| 91 |
2020 |
MRI for clinically suspected prostate cancer-the disparity between private and public sectors. |
PCa |
| 92 |
2020 |
MRI of Bladder Cancer: Local and Nodal Staging. |
BC, LN, TURBT, UUT, VI-RADS |
| 93 |
2020 |
MRI-targeted biopsy versus standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis of randomized controlled trials. |
PCa, RCTs |
| 94 |
2020 |
MRI-targeted or systematic random biopsies for prostate cancer diagnosis in biopsy naive patients: follow-up of a PRECISION trial-like retrospective cohort. |
csPCa, GG, SB, TB |
| 95 |
2020 |
MRI-targeted prostate biopsy: key considerations for pathologists. |
--- |
| 96 |
2020 |
MRI/TRUS FUSION guided biopsy as first approach in ambulatory setting: Feasibility and performance of a new fusion device. |
csPCa, DR, MRI/TRUS, PSA |
| 97 |
2020 |
Multiparametric deep learning tissue signatures for a radiological biomarker of breast cancer: Preliminary results. |
AUC, DCE, DS, MPDL, SAE-SVM, SSAE |
| 98 |
2020 |
Multiparametric Magnetic Resonance Imaging Alone is Insufficient to Detect Grade Reclassification in Active Surveillance for Prostate Cancer. |
AS, NPV |
| 99 |
2020 |
Multiparametric magnetic resonance imaging and multiparametric magnetic resonance imaging-guided biopsy in the diagnostic pathway of prostate cancer. |
--- |
| 100 |
2020 |
Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study. |
CR, MRI |
|
A Search Service for Abbreviation / Long Form
